Jump to:

Bliley PM

RE: Summary CTR Research Conducted by Bio-Research

Date: 11 Jan 1988
Length: 10 pages
2023082444-2023082453
Jump To Images
bliley_pm 2023082444-2023082453

Abstract

Provides overview of the relationship between Bio-Research and CTR (Council for Tobacco Research). Discusses the historical relationship between CTR and Dr. Freddy Homburger. Details studies done by Dr. Homburger for CTR and others. Recounts the deterioration of the relationship between Homburger and CTR.

Fields

Notes

Includes PM internal Bates numbers

Company
Philip Morris Cos., Inc.
Type
Memorandum
Author
Barnett, Orville L (PM; BW Attorney, Shook, Hardy & Bacon)
Smith, T.R.
Recipient (Organization)
Philip Morris Research Document Reviewers
Named Person
Bernfeld, P.
Braunstein, H.
Charles, J.
Dontenwill
Fagab
Gardner, Dr.
Graves, J.
Hamperl
Hockett, Robert Casad, Ph.D. (CTR Scientific Director)
Scientific Director of the Council for Tobacco Research from 1972-1974 (WSJ 2/11/93; Allman complaint). Bio-Research Institute BRI conducted a study for the CTR. When Syrian hamsters were exposed to smoke twice a day for 59 to 80 weeks, 40% of those of a cancer-susceptible strain and 4% of a resistant strain developed malignant tumors (WSJ 2/11/93). Before publishing the study in 1974, BRI's founder, Frederic Homberger, sent a manuscript to Robert Hockett, then scientific director of the CTR. Dr. Homberger says he had to do so because halfway through his study, the CTR had changed it from a grant to a contract so they could control publication. They were quite open about that (WSJ 2/11/94. Soon thereafter, Hockett and CTR lawyer Edwin Jacob went to Dr. Homburger's summer house in Maine. Hockett and Jacob did not want BRI to call anything cancer, they wanted it to be "pseudo-epitheliomatous hyperplasis," a euphemism for lesions preceding cancer (WSJ 2/11/93). Dr. Homberger said no, this is not right, it is cancer. Jacob told Dr. Homberger that BRI would never get a penny more if the paper was published without the changes. At the last minute, Dr. Homberger changed the final proofs to read "microinvasive" cancer, a microscopic malignancy. Nevertheless, BRI was never funded by the CTR again (WSJ 2/11/96) Hochett made a statement, as scientific director of the CTR circa February 1972 that neither tobacco and health research in general, nor that of the Council for Tobacco Research has established that tobacco use or cigarette smoking in particular is a major health hazard (Allman complaint, pp. 41-42). Robert C. Hockett was Scientific Director, Vice President and Research Director of CTR. See Bio-Research Institute, TTLA Almanac - Names. (N.M.'s CTR Who's Who)
Holtzman, Alexander (PM Asst General Counsel. 1975-85.)
Homburger, Freddy, M.D. (Claims CTR tried to prevent him from publishing his research)
Plaintiff
Hoyt, Willson Thomas (W. Thomas) (CTR, President, Executive Director 1954-1984)
Previously with Hill & Knowlton
Huebner, Gilbert Dolan (Medical Director for the Tobacco Institute)
Gilbert Dolan Huebner was the Medical Director for the Tobacco Institute. (PMI's Introduction to Privilege Log and Glossary of Names, Estate of Burl Butler v. PMI, et al, April 19, 1996)
Kreisher, Dr.
Kuschner
LaBelle
Leuchtenberger
Little, Arthur D. (Arthur Little died in the 1930s. References to Arthur D. Lit)
Defense
Nettesheim, P.
Ramm, H.H.
Rosenkranz, Dr.
Sommers, Sheldon Charles, M.D. (CTR Scientific Director c.1979, Industry Consultant)
Dr. Sheldon C. Sommers was an Industry Consultant, CTR Scientific Director and served on the CTR Scientific Advisory Board. (PMI's Introduction to Privilege Log and Glossary of Names, Estate of Burl Butler v. PMI, et al, April 19, 1996)
Wakeman
Wynder, Ernst L., M.D. (Epidemiologist, Sloan Kettering, Anti-Tobacco Expert)
1993 First scientist to report in 1950 on the carginocencity of cigarettes in rats painted with tar. Assistant at Sloan-Kettering Institute for Cancer Research Directed the American Health Foundation (AHF) from 1984 to his death in 1998.
Zahn, L.S.
Named Organization
Bio-Research Consultants, Inc.
Bio-Research Institute (Conducted studies for CTR)
Conducted study for Council for Tobacco Research on hamsters exposed to tobacco smoke, finding that it produced malignant tumors.
*Council for Tobacco Research-- U.S.A. Inc. CTR (Formerly Tobacco Industry Research Committee (TIRC))
Created and funded by the tobacco industry to award grants to study of the link between smoking and disease. Part of a four decade effort to cast doubt on the links between smoking and disease.
AMA-ERF
ASEP
Federation of American Societies for Experimental Biology
Richmond Times Dispatch
ORNL
*Scientific Advisory Board (SAB) (Only use SAB with name of specific org.)
Additive
Benzo[rst]pentaphene
d-limonene
DBP
Diacetate
Dibenzoate
Quinone
Terpenes
Keyword
CTR redbook
Tumorigenicity
Anti-tumorigenic
World Conference on Smoking and Health
Thesaurus Term
industry sponsored research
tobacco industry internal policy
tobacco industry scientist

Document Images

Text Control

Highlight Text:

OCR Text Alignment:

Image Control

Image Rotation:

Image Size:

Page 1: 2023082444
M E:M O R A N D,U M TO,: FROM: DATE: RE:: PHI:LIP MORRIS RESEARCH DOCUMENT REVIEWERS ORVILLE L. BARNETT,~ X-C2:~8 THERESA R. SMITH, X-C206 JANUARY ii, 1988 SUMMARY CTR RESEARCH CONDU~CTED BY BIO-RESEARCH Overvilew Bio-Research received its first CTR.grant in 1955. They continued to receive grants from CTR until 1970. In ~970 they entered into. a contra~ct relationship with CTR.. This continued until the end of 1973. In March 197'3, the SAB! elected to close out the Bio-Research contracts. Prior to this CTR and Bio- Research, appeared to have a very good working relationship. Dr. Hockett and Freddy H,omburger, most of awl, seemed to have mutual respect and admiration four one another. Durfng the 1960:'s CTR relied a, great deal on Homburger for his opinions and research. It was. not until the late 1960's andi early 1970's that criticism of Homburger became preva~lent among the SAB and CTR staff. After th.e cancellation of h of: CTR. In gelneral, CTRs' criticisms w,ere related to Homburger' s techniques and interpretations, not of Homburger himself. On the other hand, Homburger attacked CTR on a, persona~ level. He accused them of trying to suppress results and hide important information from the: pub~ic. Except for Zahn's involvemen~ in. the cancellation of Homburger"s ~r~s conference~~-R ac~~~~ ~--~--~f~--~u',,,~ manner. Cost. Bio-Research was comprisedl o:f two separate: entities,~ Bio-Research Consultants, Inc. and B~o-Research Institute, Inc. Bio-Research In,st:itute was a non-profit entity while Bio-Research COnsultants was for profit. CTRuti~ized both~ organizations. Over a period of m~e~en ~.~. ~ ,. ;~i~-w~march received o_v.er ~i. 5 ~[ll~ion from C~. [See Atta,chment A]
Page 2: 2023082445
Memorandum to: Philip Morris Re:search Document Reviewers January ~i, ~988 Page 2 Historical V~ew of CTR and Homburger's Rielationship 196i0-~969~- Building a Relationship Hockett's respect for Homburger's work wa~s very ev~d,ent in th,e early 1960"s. For instance, the Leuchtenberger's research had been, yieldingi some important results, but they did not have the capabilities to~ follow up on some of the results. Hockett suggested to Dr. Little that Homburger's laboratolry follow-up some o~f the Leuchtenberger'~slea~dS ~LT00~04147/4~48, Ex-list]i. In 1963, Hockett sent Peter Hamil~copies of H,omburger's~paper, "Mouse-Skin, Painting with CondensatesofPipe, Cigarand CigaretteSmoke~s,~[PM10!05!~012807.,. Ex-list]. The~ midl to late 19610's were marked by mixed asse~ssments of Homburger. In a memo. from ~akeham to~ Osdeme it wa~s. stated that the SAB was c~nherned about H,omburgelr's capability of performing his grant program. The SAB decide!d that Dr. Sommers and Dr.. Kreisher should visit Homburg,er's! ~aboratory andl ~nspect his facility [PMI00003!7173!,~ produced]. Apparently, Hockett had a different a:ssessment of Homburgers.' abil~t~es. In 19~69, Hockett wantedl to follow up some of LaBelle's ~ork with~ "~ong term experiments with Kotin, Homburg!er,. Mascon, Leuchtenberger or some other chronic inhalation 'expert'~''~ [!HK00~!5015/51016, taken]. Dr. Sommers respected! Homburqer"s work enough to ask Homburgerto supply Dr. Herb~ertBraunstein (Un~v.ersity of Kentu,cky) with histologic slides.~ The slid,es demonstrated squamous cell carcinomasproducedbytobacco smoke cond~insates[HK0:861605, taken]i. Homburger apparently, complied becau~se Dr. Braunstein toldl Sommers that Homburger ~ad been very helpful [HK018660~60,. taken]. Dr. Braunstein also mentioned! in the letter that he and! Homburger both, found the current commercial c~garettes to. be "poorly carcinogenic for mousse skin~." Dr. Sommers re~spondied to this ~etter and statedl if Braunstein and Homburger were correct "the 'safer c~qarette' is already that b~ng soldl commercially" ~HK086606~,~ taken~]. By ~ate 1969 there w,ere indications that H,omburger's~ ability was a,ga~n being~qu,estionedl by CTR. Another site visit was! made to Bio-Research. On. th~s occasio~n Dr. Huebner made thereport. Dr. Huebn,er'~s as~sessment of Homburg,er's laboratory wa~s that it was best suited for studies o~f in vivo. carcinogenesis. He saidl "the weak link in. Hombur~er's 0Pera~ion is the lack o~~ v~~d! tissue culture competence an~ ~tron~: an~ knowledgeable &~ien~ific personnel" ~nK0:8660136-6037, taken].
Page 3: 2023082446
Memo~randum to Philip Morri.s Research Document Reviewers Janu~ary 11, 19188 Page 3! 1970-19~74 - H, ombu'rqer' s Demise ~n May 1970 Homburger aD~D!ie~ ~ The title of his application w~s. "'Inhalation Carc!in~s! andViruses in Syrian Hamsters.,,~ Dr.. Kotin"~recommended diisapproval because the omnibus nature and confused text o~f the application~ preclude evaluation of! the indiv.~d~a~ components." Dr. Kuschner "thought the project was trivial and costly," and recommended rej'e,ction. The a~Dlication w~s d~ed bi~ ~'~e ~m~tee [Macensk~ ~: Exhibit 4,~ Ex-~Iist]~ At this same time Homburger began his contract ~or determining the usefulness of the Syrian hamster for inhalation studies with CTR. It is interesting that Homburg,er wou~d apply to both the AMA,ERF and CTR to do ba~sica~ly the: same research. Regardless of the criticisms about his research, CTR found Homburger helpful outside of the: laboratory. In N,ovember 1972, Homburger was invited! to attend a workshop on "Endpoints in TObacco Smoke ~nhalation Studies" spons~ored by O}~NL. Homburger informed Hockett o~fthis wo~kshopand Hockett d!iscussedthe workshop with ~r. Paul Nettesheim.. Dr. Neltteshe~m explained the conference to Hockett but was not "receptive to. the addition of another ob:serv.er or commentator for the Council." Hockett said Homburger wa,s g~ven permi.ss~on to attend, as we~l a~s. Dr. Bernfeldi and Dr. Rosenkranz (MRI) [ZN15722-57~23!,. taken~]. Dr. Homburger submitted a report of this meeting to Dr. H,ockett ~ZN15!724-57.27, taken]. ~n 197'3 H,omburger's relationsh~ip with CTRI came to an explosiv.e conclusion,. At a CTR annu~al meeting, in January 1973, the re!sults o~ Homburger's ~nha,lation research w~th Syrian hamsters was f~rst repolrted. According to Zahn's noltes of the meeting, Homburgelr reported info~mally toSommersthat, he found larynx cancer in hamsters, exposed to smoke. The notes went on to say "but [laryngeal] changes ~real] mild. But not sev.ere [andl] is. not [can~cer] not even clo:se ~and] can't be called, precancerous. Only mild dysplasia" [Z~497-499, taken]l. Ironically,. these results occurred a.t. the same time Dontenwi~l"s_ manuscript on nls hamster studies was comlng ou~. c'x~ an~u~nce~ a~ ~ne Janua~y'l~ ~ee~ng ~na~ ~ney Were ~rying to ha~e someolne look at Dontenwill'.s slides. That someone turned out to be Professor. H~. Hamper1. Dir. Sommers wrote to hiim and. explain~ed that Dontenwill reported squamous cell carcinomas of the la~nx ~n smoke-exposedl hamsters.. Sommers sa~id "having been stung so often with dysplasia cl!a~med to be carcinoma, we wonder if he really has invasive squamous cell carcinomas, and ii~ so how many." Dir. Somme~rs sa~i!d CTR~wouldpay~rofesso~rHamperl,~s expenses if h~ewo~d!arrange tol look at Donte~will's slide~ [HKI008!3041,. taken]. Professor Hamperl agreed and told! Dr.. Sommers that he asked Donte~.~ll~ to
Page 4: 2023082447
Memorandum to. Philip Morris Research. DocumentReviewers Jlanuary ii, 19:88 Page 4 send! him sectio~ns from the lesions! o~f the larynx. "For different not very convincing reasons he would not comply with my request and invited me instead! to come to his laboratory and see for myself" [HK0~083!O40, taken]. I have located no further correspondence onthismatter. It ~s obvious that CTRwa~sco~ncerned that both Homburger and Diontenwill came up with the~ same results. It was not surprising that by March 19173!, Homburger,s laboratory wa~s. being categolrized by CTR as "dirty" and "loaded w.ith~ ~nfections." In notes of the meeting it was said that the CTR staff ~ould holt consider it for an, inhalat~o~n study folr this rea~son. Again, a discussion was held about Homburger's cla!~ms that laryngeal tumors had developed in his hamsters.. Dr. Sommers said Homburger was "'a reliable pathologist but Freddie tendis to a liberal interpretation, [PMI000256~I0-.6113, produced]. ~pparently other SAB members felt differently and votedl that the Bio-Research contracts should! be c~osed out [[SM02OO24-0032, Rev andi Ex-list.].. In September 19~3 Peter Bernfeld a,sked CTR for renewal of Bio-Relsearch"s contract "The Determination o~f the Usefulness of the Syrian Golden Hamster a,s Model Animal for Inhalation S!tudies" [i0102.638095-810~,. produced]. This application ~as denied and Homburger became very disgruntled. He reacted by writing a letter to many of the research d~rectors of the tobacco companies. H,e felt they should, be aware of CTR's. a,ctions [LORI 0119~574, producedi]. Attachedi to this: letter was a letter h~e wrote to Dr. Gardner outlining his! intense d~sapprova~ o~ CTR'~s actions. [PM i000~8~!971-39178, ~x-list]. This letter gave a. chronology of events lea,ding up to the cancellation~ of this contract.. The chronology i.nclud~dI accusations that CTR believed Homburger"s hamsters were infectediwith, a virus. A,ccordingtoHomburgerthishadibeen checked and proven to have no scientific bases. In the letter he requested that CTR recolnsid.er their decision. ~r. Gardner respondedl to H,omburger by s~aying "no useful purpose wou~d be served by detailed reference to thee mistakes and distortions contained! in them[Homburger's!letterand chronology]."' Gardner went on to say that CTR did wish to expedite publication olf the results. H.e said CTR' could not agree, however, to "~fragmentaryorimprec!ise publicatiolns, which maybe misinterpreted. Therefore, we must insist on your observing your contract .obligations not to. publish without our approval"' [RJR 51036549017- 4.909., Ex-list]. Homburger demandedi an apology from Gardner four implying that he might publish something "fragmentary"' or "imprecise."' H,omburger said CTR's decision was"indefensible~ and w.asteful from the point of v~ew of the gelneral public. It couldl be inferredi that
Page 5: 2023082448
Memorandum to Philip Morris Research Document Reviewers January ll,~ 19:88 Page 5 you wish to. suppress, rather than to~ encourage, scientific investigation"' ~RJR510365490!5-4~9061, Ex-~ist]!. Homburger was upset that CTR wanted photographs o~f the ~esions. He said that Dr. Sommers had a chance tlo. examine in detail several o~f the original microscopic slides. 19174~-1975- Presentation, of the Results. to the Public In April 1974~, H,omburger submitted!his manuscript "Strain Differences In, Thee, Respolnse Of ~nbre~ Svri~ w~m~ ~n ~arett~i ~moke" to CTR. T~e.-~anus6ript acknowledged CTR's support, but 'said--~it]he views expressed in this paper are those of the a~thors! and do not reflect the opinion of t'he ~ouncil for. Tobacco ~esearch,,~ [ZN19~62!6-9670, taken]. H,omburger presented this. at a mee~ingl in ~tlantic City. ~n a mem6Uto, n~ ~mm an~ T. Hoyt, Zahn~ descriDed~ h~w he ~epr Homburger from holding a press, conference at th~is' meeting. Mr. Zahn had engaged! the help o~ Judy Graves, who said! some of the AS~P people consid,ered Homburg!er an "operator" [ZN19,604-9605, Ex-list]. Zahn's notes of th~is Atlantic ~ity meeting attribute some very unfortunate statements to. Homburger. Kccording to his notes, Homburger said "Good friend - Research Director of CTR- has asked me to withdraw paper pub in abstract form [and] since I wanted to give d~ta, I put together someth~ing they've approved." The rest o~ the notes reflect the details o~ Homburger's presentation [ZN191617-96~O, taken]. The t~ed notes, of this meeting of the Federation of American Societies for Experimenta~ Biology are more damaging~: Since my good friend, the Research~ Director o~f The Council for Tobacco Research., has asked me to withdraw the paper that has been published in abstract form andl since I do not wish~ to violate my contractual obligations, at the same time ~i do not wish to d!isappoint this audence [!sic]. I have p~t to~ether some:things that have been previously published with the permission of The ~oun~cil fo~Tobacco Research which u~til a very short time ago supported these stu,dies [ZN~i5~5-3528., taken]i. In June 1974 Homburger wrote a very c~rdia~ letter to Dr. H,ocket~. He than~ed"D~. ~,~,~ f...~ d~'m-~,,~ re~!~w of ~is paper. "Cigarette Smoke Inhalation Studies in~ Inbred syr~a~ ~ams~ers~" n~u.~e~ saidl ~e pa~er had been publlication i~ the proceedinqs ~f the .S~at~]~, S~vmDosium
Page 6: 2023082449
Memo~randum to: Philip Mo~rris Research Document Reviewers Janu~ary ~i, ~9:88 Page 6 Experimental Respiratory Carcinogenesis.. He asked if CTR wouldl pay folr his and Bernfeld's expen,ses to attend the meeting [ZN19612, Ex-list]. It is not c~ear whether CTR paid four his expen,ses, but Homburger d~d attend the meeting andi presented his. paper. In a memo to Holtzman, Wakeham relayed Fa,gan's analysis of the CTR-H,omburger controversy [PMI004'864285-428i6., not produced]. PM found Homburger and his organization to be very respectful of PM suggestions on~ how project work was conducted. PM felt that if there were deficiencies su,ch as those claimed by CTR, they could have been solved with proper communication~ and coordination. In October 1974, J~im Charles (IPM) visited Bio-Research. Peter Bernfeldi toldl him that "'in the CTR study' w~th hamster inhalation ....... a viral screen was performed~ at CTR"s request. Peter insisted' on blind cod!ing and he stated Huebner wa~s. ~urious. Results of vir.al stud!ies apparently showed no relation to~ inhalation results," [ 1003114289-429:2, produced]. 1975-1.981 - The Aftermath In Zahn's typed notes, for presentation at the ~975 CTR annual meeting,~ the ~omburger press conference was mentioned again:. The dliscussion of Homburger was crossed out so this may indicate he did not actually present this at the meeting. The notes say: Homburger -- unique in my 2'0 years with industry (today). A grantee who ha~dl project turnedl into, contract, scheduled press conference:: censorship of this findings, etc.. Got press conference killed, without his knowingi why or how. Did not try to get his release on, his sch,eduledi talk out of press room, but arr.anged to g!et him out when he appeared next day. No. press mention of this report [ZN474-477, Ex- i i st ] . an article appeared in the Richmond Times 19~78 Dispatch,. It detailed Homburger ' s results and subsequent cancellation, of ~is. CT~ contra~t [ZN196~5., taken]i. CTR prepared press releases to rebut the accusations made in the article. [ZN19609, 19610 Ex-list]. There was no indication whether these were ever run. Zahn addressed the press conference fiasco agBin at the 1981 Tobacco Co~loquium. Zahn explained in his presentation that if one grantee complained publicly that CTR had tried to. influence t~e research or the results it wou~d d~stroy its credibility.
Page 7: 2023082450
Memorandum to, Philip Morris Re,search Document Reviewers January II, 19,88 Page 7 Therefore, he said one hadi to believe that grant recipients we!re independent and free to do their work and disclose~their~ findings. At this point~h~edescribed a case that he said related to this area. The man, I learned, wa~s to tell the press that CTR. allegedly had tried to influence him. to chang!ehis findings andha~dlrefu,sed tocontinue its support of his work. I won't go into detai~, but the grantee had d~ne a poor of research, was really trying to: bla~ckmail the Council,. and was upset that anoth,er scientist had recently published findings similar to his. I so informed th,e public information representative and officers of the o~rgianization andl said! I was prepared to issue a statement to that effect. The result of! th~is was cancellation of the press conference. It ~ould appear that Zahn tried! to ju~stify his actions by categorizing. H,omburger"s actions as "blackmail" [T0~64,~21~/41.29, taken]. Bio-ResearchProjects Eun~edl by CT~ ~ It was very difficult to ana~yzeth~e B~o-Research research funded by CTR. The primary problem being the correlation of researchgrant or contract with the completed report. Perhaps not a~ll the d~ta was containedl in the PM fi~es or perhaps Bio-Riesearch was! negligent in preparing~ formal reports. If it ~as the latter, this could have been an underlying factor in the breakdown o~f relations between the two. institutions. An example of this problem was th,e Homburger report on, his CTR Contract 4. The purpose of this work conducted in th~eearly ~970'~s was to determine the effect of exposing mousse skin to fresh whole smoke. A. complete report on this work. w.as not found in th~e:PM files. Evid.ently in 1982, someone at PM was interested! in seeing, the data,, Homburger sent PM a copy of a summary of the data with an~ acknowledgement r~ceipt from CTRI which had a 1973 date. This exchange couldi mean that CTR staff personnel were of! the opinfoln that Homburger never submitted a report. Regardless of problems ~n reporting~, h,is! research didl have some important a~spects. I~his 1.96!7 grant application he said! ~arcin~genicity and co-carcinogenici~y ~ad ~eclin~~ in mouse~s.ki.n! ~a~inting~stu,dies since 1960d~e to. chan~esinci@arette composition. The title o~ the grant was "Bioassay of Tobacco. Smoke Condensates. and Relatedl Problems" [PMI0035468!24-'68~32:, Ex-list]!. His 196!7 manuscript, presented at the Worlld Conference o:n Smoking and Health,
Page 8: 2023082451
Memo~randum to. Philip Morris Re,search Document Reviewers January ii, 19~88 Page 8 stated: "w,e are, not co~cern~ h~ ..... ~ ~ ...... ~- ..,~~ ~h~, [gkin palntinq carc~0qen~cityl bears any relat~io~shiD: ~Q ]inng -. can~er-~ ,'" The manuscript was titled "Experimental Studies On The ~nhibition Off Carcinogenesis ByCigarette Smoke COndensates And Carcinogen-Related Substances" [PMI0050500:88-010~5, Rev-list]. Notes by Wa~eham. (.PM)I on CTR redbook sheet for th~s contract said the philosophy behind the study, was "that if the jlet is! different from th,e skin painting there may be ju~stification for discrediting and/olr abandoning~ skin painting as a'relevant' bioassay technique" [PM100Q22189~68!, produced]. In 197'11 Homburger began a contract titled, "An Expanded Study o~f Mouse Skin Exposure to Whole Fresh Smoke Compared to Skin Pa~inting:." Sgecific:Project Summaries Bio-Riesearch conducted! a mouse skin painting experiment for CTR which compared pipe, cigar and cigarette tobacco. In th~s trial all of th,e tolbacco u~sed to col~ect condensate was smoked, in, the same maunder as c~garettes. The combu~stion, temperature o~f the cigarette-like materials was very similar to cigarettes. The m~ce. receiv.ed 62 to: 6,4 mg of condensate per week for up to 1.14 w, eeks.. ~sedlon,.~iina~ t,,~i~i~__~c_!@~ ~h~ ~qt~qnificant d~ffereDces b~etweenthe:.condensiates[!PM10,05134i551-45i86, taken]. This!repo~°c~as~ a~ ~D~.isne~.__ Bio-Research conducted a projlect fund,ed by CTR. to compare the tumorigenicity of conventional, smoke condensate with: smoke condensate obtained by impingement. (Contract4)i Aftertwo years of convention:al skin pa.int~ng85.5%! of the miceexhibited!papi~lomas as opposed! to papi.l~omas; on 18.7 to: 310.2% of the mice exposed to fresh, smoke. The investigations! concluded that the lower tumorigenicity of instant over precondensed smoke condensate was due to d~fferences in. the level of ca,rcinogens in the two types of condensate. A complete repo:rt of this work wa:s not found in the PM f~les ~PM10i021970101-011, taken]i. Bernfel~ and Hombur~r published the: data obtained from the CTR Gr~:~ ~. The titl!e of this publ:ication was! "strain! ~l~erence:s in tb~ ~cn~z ~: ±~.~r~, ~y~.~a~ ~.amsters t~'"Ciq~r~ Smoke ~nhallation." ~n~ this work they found over 90% of the: smok:e ....... __ .... ~tlc or. neo~las~ic ~n~anse!s in the laryn~x. However, microin_v_91s~Me cancer was nearly 5 ~ ~ /=eq~e~ in q ~.t~ii'n ~n ~, ~h~ ~th,er [PMI00480i0440- 6~, ±ui~2967531~7.5~I~ holt produced, publi.she~]i. B~o-Nesearch played! an a,cti~v.e role in the development of smoking machines. Through CTR funding andl the con~sultant services
Page 9: 2023082452
Memorandum to Philip Morris Research Document Reviewers January ii,. 19188! Page 9 oil R. Walton, a, smoking machine was developed. This machine was criticized by many researchers, because the cigarettes! were smoked in a, vertical po:sition and air wa~spu~sh,ed through the cigarette by creating positiv.e pressure on the c~al end of the cigarette. This machine wa~s used in the acute inhalation o~f smoke to mice experiments conducted for PM!. CTR fun~ded the Bio-Research work on the effect of tobacco condensate injections on the incidience of lung tumors in mice. The results indicated that the tumor growth was. inhibited but the number of tumors! present was not effectedi. Bio-Research felt that the smoke condensate inhibitedl tumor growth, by either competing~ with, the carcinogen for available sites of metabolic activity, effecting tumor growth or havinga chemotherapeutic effect. This work a~iso demonstrated that the g.rowth rate of! subcutaneously induced sarcomas wasinhibitedbythe injiectionof smoke condensate. Bio-Research, also condu,cted research, on the inhibition, of' tumors by injections of derivatives of benzo[irst]pentaphene (iDibenzpyrene). The derivatives evaluated were the diacetate, dibenzoate andl quinone. Lung~ tumors were developed in the mice by injections with dibenzpyrene and then the derivativ.es of the carcinogen, were injected into the~ mice. All three of the: d,eriv~atives of DBP reduced! the carcinogenicity potency o~f DBP. Additional workwas conductedi on transplanting subcutaneous tumors induced in, mice to additional mice. The quinone d,erivative o~f ~BP resulted in inhibitioln of growth of transplanted tumors while the diacetate and benzoate: had no, significant effect. Bio-Research did not fee~ that the quinone derivative o~f DBP would be: usefu~ as an addiitive to cigarettes because of its low volatility. They felt that mo~re volatile anti-tumorig!enic compounds should! be investigated as! cigarette a,dditives. They a!iso, plo~nte~ ~,~ that these additives may or may not have any re~ationshi~ to safety_to ~an..~he. reason b~ing that the researcher was focused on the -- carclnogenlc: effect of smoke condensate~ to mouse skin not on the carcinogenic effect on man [I010505008!7-0105,. Ex-lis!t]. Bio-Research conductedl research funded by CTR~ on the anti-carcinogenic properties of natural terpenes.(citrus oils), d- ~im~nene and the oxidation products of' d-~imonene.. T.h~is: work demonstrated that the ~njection of orange oils! and d,limonene reduced! the growth rate oil inducedl subcutaneou~s tumors. Limonene injections reducedthe number ofspontaneousand inducedi~ung tumors in mice [i003113!23!~'3251,. not produced]. No formal report was found on the MSP work conducted! by Bio-Research, for CTR, on/2~decline in tumorigenicity of smoke colnd,en!sate. ~owever, in ~tter to Holtzman of PM, Homburger
Page 10: 2023082453
Memorandum to Philip Morris R~search Document Reviewers January Ii, 1988 Page i0. reported that he had determined that the tumoriq,eni, city of WSC ha~i decllnedl du~i~g the past decad,e. His. r~sults co~firmed th~e:re~ul~ts Drl Wynde~ [PMI~O!50,50,010-0i011, not produ,ced]. The results of work on a~ccelerated~ carcinogen testi~ng I/ was presented by H,omburge~r at the s~econd re~sea~rch co~nference on tobacco and h, ea~th for AMA-ERF grantees (.1970). The objective for the project was to shorten the time required for the d~tectio'n of ca.rcin~ogenic activity. The data presentedl indicated that transformed malignant cells, exist in carcinogen injection sites four weeks after the injectioln~ of the carcfnogen. [:PMiOi0003689!9- 699.7,~ produced, taken,]. ~mm\,mOOO~9\KRS\OLB

Text Control

Highlight Text:

OCR Text Alignment:

Image Control

Image Rotation:

Image Size: